Aditya is an Associate Partner; Clinician (Certified Genetic Counsellor) and Healthcare and Life Sciences Industry expert with the IBM Watson Group. His principal role is global business development, sales and strategic leadership of Watson engagements.
Aditya has nineteen years of health care and life sciences expertise and has worked on over thirty engagements in healthcare transformation, pharmaceuticals / biotechnology, digital hospital, strategy and information technology engagements involving E-health, diagnostic imaging, genomics and hospital operations. Aditya has a special interest in healthcare transformation, genomics and oncology.
Prior to joining IBM, Aditya worked at Mount Sinai Hospital as a genetic counselor and internal operations coordinator, where he delivered medical genetics services and promoted the role of genetics at the strategic, operational, research and management levels. His clinical experience has provided him with a unique perspective on the health care system. Aditya is a co-author of “The evolving promise of Genomic Medicine”, IBM’s point of view on Genomic Medicine, “Healthcare 2015: Win-Win or Lose-Lose” and “Redefining value and success in Healthcare” – IBM’s global point of view of healthcare in the next decade and has written other thought leadership papers such as “Healthcare in India – Caring for over a billion” and “Genomic Medicine – The Tip of the iceberg”. His extensive consulting experience in different facets of complex healthcare engagements provides for a unique blend of clinical, business, and thought leadership skills.
Aditya finished his Bachelor’s degree with Honours in Life Sciences and Biochemistry in India, and has since then completed Masters Degrees in Medical Genetics at University of Newcastle upon Tyne, UK; Molecular Genetics at McGill University and Genetic Counseling at Brandeis University, Boston. He completed his MBA at Schulich School of Business, York University with a specialization in Strategic Management in April 2004 and was the Founder of Schulich’s Healthcare and Biotechnology Forum. He has taught genetics courses at the post-graduate level at University of Toronto and has subsequently joined York University as a Part-Time Faculty member where teaches an MBA course that he co-designed in the Health Industry Management Program at Schulich School of Business on Commercialization in Biotechnology and Pharmaceuticals. Aditya has lived in India, South America, UK, and the US and is a Certified Genetic Counselor and Diplomate of the American Board of Genetic Counseling.
As we enter the “era of big data” we are facing a deluge of data – our challenge will be how to turn data into knowledge. A few years ago IBM made headlines by competing on the game show Jeopardy! with a computer they named Watson. Today Watson represents the beginning of the “era of cognitive computing”, building on natural language processing and machine learning technologies.
Watson is already starting to impact our lives, from aiding an oncologist by providing personalized clinical decision support around a specific cancer treatment; to helping individuals make sense of the income tax act; to assisting financial analysts in determine in which companies to invest. The range of potential applications for Watson is limited only by our imaginations.